calendar

352 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 98 grant

next 91 dayslessmore

MonWedFri

view

sort

phase 1 completion

73

therapy area

Date TBD

2

TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

page 8 of 8

next →

$NVS154.05-0.37%

$ABBV248.08-0.73%